Vitamin D Treatment in Patients With Chronic Hepatitis C
1 other identifier
interventional
N/A
1 country
1
Brief Summary
We hypothesize that patients with Ch.HCV have a low level of vitamin D, and that by raising their vitamin D levels by adding it to their standard treament of Pegylated Interferon and Ribavirin, there will be an increase in their sustained virological response.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 7, 2008
CompletedFirst Posted
Study publicly available on registry
December 9, 2008
CompletedDecember 9, 2008
December 1, 2008
December 7, 2008
December 8, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To increase the sustained virological response
One year
Study Arms (1)
Vitamin D
EXPERIMENTALAn addition of Vitamin D to the standard treatment
Interventions
Eligibility Criteria
You may qualify if:
- Chronic Hepatitis C Genotype 1
You may not qualify if:
- Vitamin D intoxication Renal Failure Liver Failure Malignancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hillel Yaffe Medical Center
Hadera, 38100, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
December 7, 2008
First Posted
December 9, 2008
Last Updated
December 9, 2008
Record last verified: 2008-12